Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Varicella Zoster Virus encephalitis in Denmark from 2015 to 2019- A nationwide prospective cohort study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Changes in Lyme neuroborreliosis incidence in Denmark, 1996 to 2015

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Risk of neurological disorders in patients with European Lyme neuroborreliosis. A nationwide population-based cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Accelerated treatment of endocarditis-The POET II trial: Rationale and design of a randomized controlled trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Otoacoustic emissions in patients with bacterial meningitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Predominance of hospital-acquired bloodstream infection in patients with Covid-19 pneumonia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • and the DASGIB study group
Vis graf over relationer

BACKGROUND: Knowledge of the epidemiology and clinical characteristics of Varicella zoster virus (VZV) encephalitis remains limited.

METHODS: Nationwide prospective cohort study of adults treated for microbiologically confirmed VZV encephalitis at Danish departments of infectious diseases from 2015 to 2019. Modified Poisson regression analysis was used to compute adjusted relative risks (RR) of unfavorable outcome.

RESULTS: We identified 92 adults (49% female) with VZV encephalitis yielding an incidence of 5.3/1,000,000/year (95% CI:4.2-6.6). The median age was 75 years (IQR 67-83) and immuno-compromising conditions were frequent (39%). Predominant symptoms were confusion (76%), headache (56%), nausea (45%), gait disturbance (42%), and personality changes (41%). Cranial imaging showed cerebral vasculitis (including infarction and hemorrhage) in 14 (16%) patients and encephalitic abnormalities in 11 (13%) with predilection for the brainstem and deep brain structures. Intravenous acyclovir treatment was initiated a median of 13.4 hours (IQR 5.2-46.3) since admission, while cranial imaging and lumbar puncture were performed after 6.3 hours (IQR 2.5-31.0) and 18.5 hours (IQR 4.9-42.0). In-hospital, 1-month, and 3-month mortalities were 4%, 9%, and 11%, respectively. Unfavorable outcome (Glasgow Outcome Score (GOS) of 1-4), was found in 69% at discharge, with age (adj. RR 1.02, 95% CI 1.01-1.03), vasculitis (adj. RR 1.38, 95% CI 1.02-1.86), and Glascow coma scale (GCS)<15 (adj. RR 1.32, 95% CI:1.01-1.73) identified as independent risk factors.

CONCLUSION: VZV encephalitis occurs primarily in elderly or immuno-compromised patients with a higher incidence than previously estimated. The diagnosis is often delayed and risk factors for unfavorable outcome are age, cerebral vasculitis, and GCS<15.

OriginalsprogEngelsk
TidsskriftClinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN1058-4838
DOI
StatusUdgivet - 27 feb. 2020

Bibliografisk note

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

ID: 59544930